Literature DB >> 16925556

Functional characterization of BbCRASP-2, a distinct outer membrane protein of Borrelia burgdorferi that binds host complement regulators factor H and FHL-1.

Kristina Hartmann1, Carsten Corvey, Christine Skerka, Michael Kirschfink, Michael Karas, Volker Brade, Jennifer C Miller, Brian Stevenson, Reinhard Wallich, Peter F Zipfel, Peter Kraiczy.   

Abstract

Borrelia burgdorferi, the aetiological agent of Lyme disease, employs sophisticated means to survive in diverse mammalian hosts. Recent studies demonstrated that acquisition of complement regulators factor H and factor H-like protein-1 (FHL-1) allows spirochetes to resist complement-mediated killing. Serum-resistant B. burgdorferi express up to five distinct complement regulator-acquiring surface proteins (CRASPs) that bind factor H and/or FHL-1. In this study we have identified and characterized one of those B. burgdorferi proteins, named BbCRASP-2. BbCRASP-2 is distinct from the four previously identified factor H/FHL-1-binding CRASPs of B. burgdorferi strains. The single copy of the gene encoding BbCRASP-2, cspZ, is located on the linear plasmid lp28-3. BbCRASP-2 is highly divergent from the factor H/FHL-1-binding protein BbCRASP-1 and from members of the factor H-binding Erp (OspE/F-related) protein family. Peptide mapping analysis revealed that the factor H/FHL-1 binding site is discontinuous and it was found that C-terminal truncations abrogate factor H and FHL-1 binding. The predominant BbCRASP-2 binding site of both host complement regulators was mapped to the short consensus repeat 7 (SCR 7). Factor H and FHL-1 bound to BbCRASP-2 maintain cofactor activity for factor I-mediated C3b inactivation and accelerate the decay of the C3 convertase. Expression of BbCRASP-2 in serum-sensitive B. burgdorferi mutant B313 increased resistance to complement-mediated lysis. The characterization of BbCRASP-2 now provides a complete picture of the three diverse complement regulator-binding protein families of B. burgdorferi yielding new insights into the pathogenesis of Lyme disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16925556     DOI: 10.1111/j.1365-2958.2006.05318.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  78 in total

Review 1.  Complement control protein factor H: the good, the bad, and the inadequate.

Authors:  Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

2.  The OspE-related proteins inhibit complement deposition and enhance serum resistance of Borrelia burgdorferi, the lyme disease spirochete.

Authors:  Melisha R Kenedy; Darrin R Akins
Journal:  Infect Immun       Date:  2011-01-31       Impact factor: 3.441

3.  Immune evasion of leptospira species by acquisition of human complement regulator C4BP.

Authors:  Angela S Barbosa; Patricia A E Abreu; Sílvio A Vasconcellos; Zenaide M Morais; Amane P Gonçales; Aldacilene S Silva; Mohamed R Daha; Lourdes Isaac
Journal:  Infect Immun       Date:  2008-12-29       Impact factor: 3.441

4.  Blood treatment of Lyme borreliae demonstrates the mechanism of CspZ-mediated complement evasion to promote systemic infection in vertebrate hosts.

Authors:  Ashley L Marcinkiewicz; Alan P Dupuis; Maxime Zamba-Campero; Nancy Nowak; Peter Kraiczy; Sanjay Ram; Laura D Kramer; Yi-Pin Lin
Journal:  Cell Microbiol       Date:  2019-01-07       Impact factor: 3.715

5.  Structural basis for complement evasion by Lyme disease pathogen Borrelia burgdorferi.

Authors:  Arnab Bhattacharjee; Jesper S Oeemig; Robert Kolodziejczyk; Taru Meri; Tommi Kajander; Markus J Lehtinen; Hideo Iwaï; T Sakari Jokiranta; Adrian Goldman
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

6.  Borrelia burgdorferi lacking DbpBA exhibits an early survival defect during experimental infection.

Authors:  Eric H Weening; Nikhat Parveen; Jerome P Trzeciakowski; John M Leong; Magnus Höök; Jonathan T Skare
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

7.  Inhibition of complement activation on a model biomaterial surface by streptococcal M protein-derived peptides.

Authors:  Anna E Engberg; Kerstin Sandholm; Fredrik Bexborn; Jenny Persson; Bo Nilsson; Gunnar Lindahl; Kristina N Ekdahl
Journal:  Biomaterials       Date:  2009-01-25       Impact factor: 12.479

Review 8.  Biology of infection with Borrelia burgdorferi.

Authors:  Kit Tilly; Patricia A Rosa; Philip E Stewart
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

9.  Essential protective role attributed to the surface lipoproteins of Borrelia burgdorferi against innate defences.

Authors:  Qilong Xu; Kristy McShan; Fang Ting Liang
Journal:  Mol Microbiol       Date:  2008-04-28       Impact factor: 3.501

10.  Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity.

Authors:  Sonja Grosskinsky; Melanie Schott; Christiane Brenner; Sally J Cutler; Peter Kraiczy; Peter F Zipfel; Markus M Simon; Reinhard Wallich
Journal:  PLoS One       Date:  2009-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.